Site Search

... all private employers with a staff of five or more to grant employees paid time off—up to five hours annually—for preventative medical care, including doctor-recommend screening, ensuring that fear of wage or job loss does not serve as a barrier to workers’ ability to prevent, ... said Michael Davoli, senior government relations director for the American Cancer Society Cancer Action Network. He continued, “Our physical health shouldn’t come at the expense of our financial well-being, or vice versa. Int. #1369-2025 would help eliminate one barrier for New York ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

... Network (ACS CAN) will host its seventh annual Texas Cancer Policy Forum series this fall, uniting key leaders and decision makers in business, health care, and government to consider the evolving needs of Texans accessing and affording equitable cancer care. Texas institutions are generating exciting new life-saving therapies and making advances in the fight against cancer, with significant ...

... and partners are working together to make sure more Nevadans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

... partners are working together to make sure more Washingtonians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...